9.0 Introduction


A major development in treating vision loss in people with DME has been the introduction of anti-VEGF drugs, which leverage recent advances in our understanding of the different mechanisms that cause DME. These drugs are designed to attack specific factors that contribute to DME development and are improving our ability to treat this condition.